Mylan Would Launch Nebivolol For Hypertension If Heart Failure Indication Is Delayed
This article was originally published in The Pink Sheet Daily
Executive Summary
Timeline could hinge on FDA’s acceptance of heart failure data from the SENIORS trial; nebivolol is currently “approvable” for hypertension.